Guide for patients & caregivers
High Chromogranin A: What Does It Mean and What Happens Next?
High chromogranin A explained: its role as a neuroendocrine tumour marker, why acid medicines, kidney function and atrophic gastritis raise it, and next steps.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a high chromogranin A level mean?
A high chromogranin A (CgA) result means the blood level of this protein is above the laboratory's reference range. CgA is used as a tumour marker for neuroendocrine tumours (NETs), but many common, non-cancer causes raise it too, especially acid-reducing medicines, reduced kidney function and atrophic gastritis. On its own, a high result is a prompt for context, not a diagnosis.
The US National Cancer Institute (NCI) lists CgA as a blood marker for neuroendocrine tumours, used to help in diagnosis, to assess response to treatment and to check for recurrence. NCI also explains that a raised tumour marker does not mean someone has cancer, because noncancerous conditions can increase marker levels, and that markers are usually combined with other tests such as imaging or biopsy.
Symptoms that need urgent care
Most people with a raised CgA feel well, and the number itself is not an emergency. New or worsening symptoms matter more than the result. Cancer Research UK describes carcinoid crisis, a rare and serious form of hormone-related symptoms in people with NETs, as a medical emergency. Seek emergency care if you have:
- Sudden, severe changes in blood pressure that make you feel dizzy or faint.
- Difficulty breathing or new wheezing.
- Sudden severe flushing of the skin together with very severe diarrhoea.
- Contact your clinician promptly (not an emergency unless severe) for blood in your stool, yellowing of the skin or eyes, ongoing abdominal pain, unexplained weight loss, or persistent vomiting. NCI lists these among possible signs of gut NETs, while noting that other conditions cause the same symptoms.
What is chromogranin A and why is it tested?
Neuroendocrine cells behave partly like nerve cells and partly like hormone-making cells. They are found throughout the body, especially in the digestive tract. CgA is a protein stored in these cells, and NETs can release more of it into the blood.
A clinician may check CgA when symptoms such as flushing or diarrhoea raise the question of a hormone-producing tumour, when a scan or endoscopy shows something that could be a NET, or to follow someone already diagnosed with a NET. In people already diagnosed, CgA levels are related to how much tumour there is, so a rise over time can be a signal for the team to look more closely.
What can cause a false positive chromogranin A?
A false positive here means CgA is raised for a reason other than a neuroendocrine tumour. This is common. A study from a Danish specialist NET centre (2020) looked at 197 people referred with a suspected NET. Of the 167 with a raised CgA before referral, only 19 were found to have a NET. The authors concluded CgA was not reliable for screening when a NET is merely suspected. Results from one centre may not apply everywhere, but the pattern is a useful reminder that a high level is often explained by something else.
Causes described in that study and in NCI and charity information include:
- Proton pump inhibitors (PPIs), a common group of acid-reducing medicines. The Danish study identified PPI treatment as a possible cause in 55 of the 148 people with falsely raised CgA.
- Reduced kidney or liver function, both listed among non-tumour causes of a raised CgA.
- Chronic atrophic gastritis, a long-term stomach condition in which the stomach makes less acid.
- Other conditions listed in the same study, including heart disease and rheumatological (joint and autoimmune) disease.
- Laboratory differences: CgA results depend on the assay used, so values from different laboratories may not be directly comparable.
Do PPIs (acid medicines) affect chromogranin A?
Yes. PPIs are one of the most common reasons for a raised CgA. In the Danish study, CgA was raised in 58 of 61 people taking a PPI at the time of the test. Among those whose PPI was paused before a repeat test, CgA returned to normal in a little over half (28 of 46). The authors recommended pausing PPIs before CgA is measured. Whether and how that happens in your case is a clinical decision.
Do not stop or change a prescribed medicine without talking to the prescriber. A PPI may have been prescribed for an important reason, and the prescriber can weigh that against the need for a clearer test result. If a repeat test is planned, ask the team which medicines to keep taking, whether any pause is needed and for how long, and what to do if symptoms come back.
Can atrophic gastritis or kidney problems raise CgA?
Yes. Atrophic gastritis reduces stomach acid, much as PPIs do, and the Danish study lists it among non-tumour causes of a raised CgA. NCI also lists conditions that affect the stomach's ability to make acid, such as atrophic gastritis and pernicious anaemia, as risk factors for stomach NETs. Neuroendocrine Cancer UK explains that the most common type of stomach NET linked to atrophic gastritis usually appears as small growths that tend to be non-aggressive and rarely spread. If you have atrophic gastritis, ask your gastroenterologist whether your CgA result changes your existing follow-up plan.
Kidney function matters too: the Danish study defined reduced kidney function by eGFR, based on earlier research showing higher CgA in people without NETs whose kidney function was reduced. If your eGFR is low, ask whether this could explain the result before further tests are arranged.
What happens after a high chromogranin A result?
Next steps depend on why the test was done. Common steps include reviewing medicines and kidney results, repeating CgA under agreed conditions, and checking for symptoms that suggest a hormone-producing tumour. If carcinoid-type symptoms are present, a 24-hour urine or blood 5-HIAA test may be added (see our guide on a high 5-HIAA result). Imaging or endoscopy is considered when symptoms, other results or a previous scan point that way, not on a raised CgA alone.
If you already have a NET diagnosis, the team will usually compare the new value with your own earlier results, ideally from the same laboratory, and read it alongside scans.
Questions to ask your clinician
Writing your questions down beforehand can make a short appointment more useful.
- Why was CgA checked, and what was the question it was meant to answer?
- Could my PPI or another medicine, my kidney function or atrophic gastritis explain this result?
- Should the test be repeated, and do I need to change anything beforehand? Who will tell me what to do with my medicines?
- Are there symptoms or other results that make a neuroendocrine tumour more or less likely?
- Will any imaging or endoscopy be needed, and what would it show?
- Who will contact me with the results, and when?
How SameCase can help you prepare
On SameCase, patients and verified doctors share de-identified cases. Reading how others with a raised CgA, PPI use or atrophic gastritis were followed up can help you notice questions to bring to your own clinician, such as whether a repeat test was done or how kidney results were considered. Other people's cases cannot tell you what your result means, and they do not replace your care team's assessment.
Sources and further reading
- National Cancer Institute: Tumor markers in common use (chromogranin A and 5-HIAA)
- National Cancer Institute: Tumor markers fact sheet (reviewed December 2023)
- National Cancer Institute: Gastrointestinal Neuroendocrine Tumors Treatment (PDQ), patient version (updated February 2025)
- Baekdal J et al. Limited diagnostic utility of chromogranin A measurements in workup of neuroendocrine tumors. Diagnostics, October 2020 (open access, CC BY)
- Cancer Research UK: About carcinoid syndrome, including carcinoid crisis
- Neuroendocrine Cancer UK: Neuroendocrine cancer of the stomach
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.